Biotechnology Startups That Raised Funding in Australia

Zelira Therapeutics

Location: Brisbane, Australia

Website: zeliratx.com

Funding: secures transformative US$33 m

Date: 161 days ago

Zelira Therapeutics is an Australian clinical-stage biotechnology company developing evidence-based cannabinoid therapies for neurological and mental health conditions such as autism, leveraging rigorous clinical research and non-dilutive funding like its US$33 million HOPE 1 Autism Program to advance safe and effective treatment options.

Racura

Location: Perth, Australia

Funding: secures $3.2M

Date: 196 days ago

Racura is a clinical-stage oncology biotechnology company developing innovative treatments for lung cancer, currently funded by a A$3.2M grant to support its clinical trial.

RAGE Biotech

Location: Melbourne, Australia

Funding: Lands $29M

Date: 225 days ago

RAGE Biotech is a Melbourne-based biotech spinout from Monash University developing precision RNA-based therapeutics using splice-switching oligonucleotides and RAGE biology to treat chronic inflammatory diseases, with the goal of advancing these novel therapies into clinical use.

RAGE Biotech

Location: Melbourne, Australia

Funding: raises $29 m

Date: 225 days ago

Melbourne-based RAGE Biotech develops novel therapies for chronic lung disease and has raised $29 million in Series A funding to advance its lead treatment into first-in-human clinical trials.

ENA Respiratory

Location: Melbourne, Australia

Funding: raises $34 m

Date: 242 days ago

ENA Respiratory is a Melbourne-based biotech company developing INNA-051, a virus-agnostic nasal spray designed to prevent and treat respiratory viral infections by enhancing mucosal immune response.

ENA Respiratory

Location: Melbourne, Australia

Website: enarespiratory.com

Funding: secures US$22.4m

Date: 247 days ago

ENA Respiratory is a Melbourne-based biotechnology company developing nasal spray therapies to prevent viral respiratory infections. Its lead candidate, INNA-051, is a once-weekly dry powder nasal spray currently advancing into phase 2 clinical trials.

Orthocell

Location: Sydney, Australia

Website: orthocell.com

Funding: secures A$30 m

Date: 252 days ago

Orthocell is an Australian clinical-stage regenerative medicine company developing and commercializing collagen-based biomaterial products for tissue repair and aesthetic applications, including its lead dermal filler Remplir and bone repair scaffold CelGro.

OxyLo

Location: Sydney, Australia

Funding: Secures $1.4M

Date: 296 days ago

OxyLo is a University of New South Wales spinout developing HypoxyCaps, a novel hypoxia-responsive platform designed to improve the efficacy of cancer treatments through targeted drug delivery.

Imugene

Location: Melbourne, Australia

Website: imugene.com

Funding: raises A$2.42M

Date: 302 days ago

Imugene is a clinical-stage immuno-oncology biotechnology company based in Melbourne, Australia, developing B-cell immunotherapies—such as cancer vaccines and cell therapies—to stimulate targeted anti-tumor immune responses.

Recce Pharmaceuticals

Location: Australia

Funding: raise $7.4 m

Date: 388 days ago

Recce Pharmaceuticals is a clinical-stage biotechnology company developing novel synthetic antimicrobial peptides to treat multi-drug resistant bacterial infections, providing broad-spectrum therapies designed to overcome antibiotic resistance.

Bovotica

Location: Brisbane, Australia

Funding: raised $11.4 m

Date: 407 days ago

Bovotica is a biotechnology startup developing methane-reducing probiotics for cows, aimed at reducing greenhouse gas emissions in agriculture.